The potential use of O6-Benzylguanine, and O6-Methylguanine for the treatment of Alzheimer's Disease, and T. brucei group trypanosomes infections
<p>Very recently we had published a paper entitled 'The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer's Disease' [1]. Our paper was a development from an observation by others from 1997, where a remarkable remission in Dementia was observed in cancer pa...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Annals of Systems Biology - Peertechz Publications,
2022-08-13.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>Very recently we had published a paper entitled 'The Potential Development Sulfonylhydrazines for the Treatment of Alzheimer's Disease' [1]. Our paper was a development from an observation by others from 1997, where a remarkable remission in Dementia was observed in cancer patients following treatment with the chemotherapeutic agent BCNU (Carmustine, 1,3-Bis(2-chloroethyl)-1-nitrosourea) [2]. </p><p><br></p> |
|---|---|
| DOI: | 10.17352/asb.000018 |